Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer [NA]

View source ↗

Summary

This clinical trial update notes a study evaluating whether a ketogenic diet can improve response to immunotherapy in patients with metastatic melanoma and meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma | NA | Status: RECRUITING